JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
Moya Moya Syndrome in beta thalassemia major- silent puff, alarming crisis: a case and review of literature
Abstract
Our aim is to report a rare case of beta Thalassemia major with Moya Moya syndrome (MMS) presenting as acute ischemic stroke who was managed with encephaloduroarteriomyosynangiosis (EDAMS). MMS is an intracranial angiopathy with progressive stenosis of the distal portion of internal carotid artery (ICA) causing development of small collaterals traversing the basal ganglia and thalamus, giving “puff of smoke” appearance. MMS presents commonly as ischemic stroke in children and haemorrhagic stroke in adults. There are only few reported cases of MMS associated with Thalassemia. We obtained an informed consent form from the patient involved. All procedures were carried out in accordance with the ethical rules and the principles of the Declaration of Helsinki. A 23-year-male with beta thalassemia major, diagnosed at 9 months of age on intermittent blood transfusion till the age of 22 years followed by chemotherapy (thalidomide 50mg once daily). After chemotherapy he did not require transfusion. He presented with acute confusional and dysarthria for 10-12 days. On examination, he had mild pallor and hepatosplenomegaly. MRI Brain showed multiple acute infarcts in left parietal, left centrum semi ovale and corona radiata along with multifocal chronic infarcts. DSA showed Moya Moya like phenomenon, Suzuki grade IV. He was treated with single antiplatelet (acetyl salicylate 75mg/ day) and other supportive measures. Left sided (EDAMS) was done 1 month after stroke, which he tolerated well. We plan to re-introduce thalidomide on follow-up. MMS along with beta-thalassemia major is rare. Any neurological symptom indicating possible stroke warrants euroimaging like MRI Brain and angiography of head-neck vessels in order to exclude MMS or other occlusive arteriopathy. Our case is unique as apart from MMS being rare in Thalassemia, very few such cases undergo surgical revascularization management.

Keywords : Moya Moya Syndrome, Suzuki, beta thalassemia, transfusion, encephaloduroarteriomyosynangiosis, thalidomide

Download Article


1. Suzuki J, Takaku A. Cerebrovascular “Moyamoya” disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969; 20(3):288-299. doi:10.1001/archneur.1969.00480090076012
2. Inati A, Tourjuman O, Bizri D, et al. A rare case of Moyamoya syndrome in a ß-thalassemia major patient. Blood Cells Mol Dis. 2013;51(3):149-150. doi:10.1016/j.bcmd.2013.05.005
3. Marden FA, Putman CM, Grant JM, Greenberg J. Moyamoya disease associated with hemoglobin Fairfax and beta-thalassemia.Pediatr Neurol. 2008;38(2):130-132. doi:10.1016/j.pediatrneurol.2007.09.011
4. Sunil A, Sivarajakumar B, Kumari V. Beta-thalassemia presenting as Moyamoya syndrome with a review of skeletal manifestations.Cureus. 2023;15(5):e38372. doi:10.7759/cureus.38372
5. Das S, Dubey S, Acharya M, et al. Thalassemia and Moyamoya syndrome: unfurling an intriguing association.J Neurol. 2019;266(11): 2838-2847. doi:10.1007/s00415-019-09497-5
6. Das S, Ray BK, Pandit A, Ghosh R, Chakraborty AP, Dubey S. Thalassemia and Moyamoya syndrome: epidemiology and long-term outcome. Eur J Paediatr Neurol. 2022;41:63-70. doi:10.1016/j.ejpn.2022. 10.002
7. Doctor PN, Choudhari A, Verma M, Merchant RH. Moyamoya syndrome in hemoglobin E-beta thalassemia: a rare presentation and association. J Postgrad Med. 2018;64(4):240-242. doi:10.4103/jpgm.JPGM_468_17
8. Zhu J, Zhang M, Sun Y, Zhang X. Moyamoya syndrome with ruptured aneurysm in ?-thalassemia: a case report.Exp Ther Med. 2022;24(3): 556. doi:10.3892/etm.2022.11494
9. El Beltagi AH, El-Sheikh A, El-Saif R, Norbash A. Ivy sign in mildly symptomatic ß-thalassemia intermedia, with development of moyamoya disease. Neuroradiol J. 2014;27(1):23-28. doi:10.15274/NRJ-2014-10003
10. Parker TM, Ward LM, Johnston DL, Ventureya E, Klaassen RJ. A case of Moyamoya syndrome and hemoglobin E/beta-thalassemia.Pediatr Blood Cancer. 2009;52(3):422-424. doi:10.1002/pbc.21850
11. Mukherjee A. Moyamoya disease and beta-thalassemia. J Assoc Physicians India. 1995;43(10):710-711.
12. Sanefuji M, Ohga S, Kira R, et al. Moyamoya syndrome in a splenectomised patient with beta-thalassemia intermedia. J Child Neurol. 2006;21(1):75-77. doi:10.1177/08830738060210010501
13. Shaukat M, Aman M, Fatima H, et al. Moyamoya syndrome in a 6-year-old ß-thalassemia major patient: a case report. Radiol Case Rep. 2025; 20(8):4076-4081. doi:10.1016/j.radcr.2025.04.129
14. Vikhe VB, Tripathi S, Vemuri SK, et al. Moyamoya syndrome in a known case of beta thalassemia major: a rare case report. Pravara Med Rev. 2021;13(04):58- 61.
15. Kumar N, Singh A, Aggarwal A.Moyamoya syndrome in a child with beta-thalassemia trait: a case report with review of literature. Indian Pediatr Case Rep. 2024;4(2):82-85. doi:10.4103/ipcares.ipcares_183_23
16. Sarkar KN, Deoghuria D, Sarkar M, Sarkar S. Moya Moya syndrome in a HbE beta thalassemic child presenting with hemiplegia in rural West Bengal. IOSR J Dent Med Sci. 2016:15(4):113-118. doi:10.9790/0853-150407113118
17. Agrawal A, Bhinder OS, Mishra D, Juneja M. HbE-beta thalassemia with Moyamoya syndrome: a rare association.Indian J Pediatr. 2020; 87(6):476-477. doi:10.1007/s12098-019-03143-8
18. Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes.Am J Hematol. 1993;44(1):63-65. doi:10. 1002/ajh.2830440114
19. Rafat N, Beck GCh, Peña-Tapia PG, et al. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Stroke. 2009;40(2):432-438. doi:10.1161/STROKEAHA.108.529420
20. Kang HS, Kim JH, Phi JH, et al. Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry. 2010;81(6):673-678. doi:10.1136/jnnp.2009.191817
21. Taher AT, Musallam KM, Karimi M, et al. Splenectomy and thrombosis: the case of thalassemia intermedia.J Thromb Haemost. 2010;8(10):2152-2158. doi:10.1111/j.1538-7836.2010.03940.x
22. Aerbajinai W, Zhu J, Gao Z, et al. Thalidomide induces g-globin gene expression through increased reactive oxygen species-mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis. Blood. 2007;110(8):2864-2871. doi:10.1182/blood-2007-01-065201
23. Yang CS, Kim C, Antaya RJ. Review of thalidomide use in the pediatric population. J Am Acad Dermatol. 2015;72(4):703-711. doi:10.1016/j.jaad. 2015.01.002
24. Gunaseelan S, Prakash A. Thalidomide-induced stroke in a child with thalassemia major. J Pediatr Hematol Oncol. 2017;39(8):e519-e520. doi: 10.1097/MPH.0000000000000860
Article available in :
Volume 4, Issue 2, 2026
Page : 70-73
https://doi.org/10.51271/JCHOR-0085
Article Information
Received : 04 Oca 2026
Accepted : 02 Nis 2026
Published : 18 May 2026
Corresponding Author :

Vinay Goyal Goyal: Department of Neurology, Institute of Neurosciences, Medanta-The Medicity, Gurgaon, India

[email protected]
Citation : Gogoi RM, Chand S, Sood N, Goyal C, Goyal V. Moya Moya syndrome in beta thalassemia major- silent puff, alarming crisis: a case and review of literature. J Curr Hematol Oncol Res. 2026;4(2):70-73. doi:10.51271/JCHOR-0085

Read: 31
Download : 109
Cited: 0
_Footer